abrdn Life Sciences Investors Shares of Beneficial Interest (HQL)
Revenue Growth
164.14%
Quarterly · Period ending:
HQL Revenue Growth
Year-over-year change vs the same period a year earlier
Latest reported164.14%period ending
Latest reported164.14%period ending
HQL Quarterly Revenue YoY % (-23.81% → 164.14%)
Year-over-year change
High-resolution chart · PNG
HQL revenue growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue Growth |
|---|---|
| 164.1411% | |
| 507.5889% | |
| 781.181% | |
| -93.5235% | |
| 7.0489% | |
| 36.297% | |
| -81.0325% | |
| 35.7426% | |
| -64.9655% | |
| -3.149% | |
| 28.6187% | |
| 1,155.613% | |
| 1,903.6686% | |
| 32.8956% | |
| 12.9886% | |
| 110,811.42% | |
| 126,002.3479% | |
| 23.535% | |
| 10.4969% | |
| -13.5548% | |
| 46.6921% | |
| 102.7838% | |
| 4.8771% | |
| 48.2851% | |
| 288.9971% | |
| -99.981% | |
| -99.9826% | |
| 411.5628% | |
| 140.8951% | |
| -68.6813% | |
| -68.6813% | |
| 295.6522% | |
| 295.6522% | |
| -72.4551% | |
| -72.4551% | |
| -42.0139% | |
| -42.0139% | |
| 25.2174% | |
| 25.2174% | |
| 158.427% | |
| 158.427% | |
| 178.125% | |
| 178.125% | |
| -47.541% | |
| -47.541% | |
| -35.1064% | |
| -35.1064% | |
| -46.8927% | |
| -46.8927% | |
| -56.25% | |
| -56.25% | |
| -23.8095% | |
| -23.8095% |